🗞 A report by the Center for Connected Medicine shares the single biggest challenge for meeting the needs of clinical trial sponsors... ⏱ identifying patient cohorts in a timely manner While the ticking clock is the top concern, it is followed closely by challenges with ... 💰 the overwhelming cost of manual abstraction 🔍 understanding how to navigate & harmonize unstructured data 🔗 lack of integration between clinician & trial management workflows Sound familiar? We can help ✅ (on all fronts!) #HealthcareIT #ClinicalResearch #AIOncology #ClinicalTrials #ClinicalTrialSolutions #AIinPrecisionOncology #NoMoreZombieTrials #ClinicalTrialsForAll #DHAI24 #AAAC24 #RealyzeIntelligence
Realyze Intelligence
Information Technology & Services
Pittsburgh, PA 777 followers
We combine AI & clinical expertise to accelerate clinical trials, harmonize RWD & drive patient outcomes.
About us
Realyze Intelligence has developed a suite of tools to facilitate clinical trial matching & data abstraction – together these tools can: - Accelerate screening & matching of patients to oncology clinical trials - Provide auto-abstraction for Real World Data needs (registry, research, etc) - Identify care pathways and pathway adherence The Realyze solution enables clinical oncology research sites to increase enrollment, target more diverse populations and turbocharge clinical research capabilities using existing resources. Our goal is to be a force-multiplier for existing oncology clinical trial & research teams. The Realyze platform leverages a combination of AI, LLMs and clinically guided expert models to analyze EHR data in real time, instantly matching patients to clinical trials. Additionally, the solution captures and makes available all the key clinical data from the unstructured notes to allow it to be imported back into the EMR, improving research and other clinical uses. -- Realyze has provided a 5x increase in patient matching for oncology clinical trials, including expanding the target locations and demographics for the identified populations. -- Realyze has processed and analyzed over 3 million patient records and well over 10 million individual medical documents across 36 different source systems/EMRs. -- Clinical teams using the Realyze intelligence solution have seen a reduction in trial screening time from 1-2 hours to under a minute per patient. -- The Realyze solution augments existing workflows and integrates the data back into EMRs & CTMSs. -- The Realyze solution acts as a force-multiplier for your existing team – freeing them from the drudgery of screening & abstraction. -- The Realyze platform has been used to identify patients to optimize value-based care programs, registry entry, care coordination, & research. -- Realyze collaborates w. leading health systems such as Memorial Sloan Kettering Cancer Center, OneOncology & UPMC.
- Website
-
http://realyzeintelligence.com
External link for Realyze Intelligence
- Industry
- Information Technology & Services
- Company size
- 11-50 employees
- Headquarters
- Pittsburgh, PA
- Type
- Privately Held
- Founded
- 2020
- Specialties
- Healthcare, Technology, Healthcare Data, Natural Language Processing, Artificial Intelligence, Clinical Natural Language Processing, Electronic Medical Records, Oncology, Clinical Trials , Precision Oncology, Data Abstraction, Real-World Data , Natural Language Understanding , Oncology Research, Oncology Clinical Trials , Healthcare Disparity, Oncology Disparity , RWD Harmonization, Clinical Pathways, and Consulting
Locations
-
Primary
6245 Penn Ave
#200
Pittsburgh, PA 15206, US
Employees at Realyze Intelligence
-
Aaron Brauser
Co-founder and Chief Executive Officer at Realyze Intelligence
-
Craig B.
Healthcare Investor | UPMC Enterprises
-
Samantha Lavrinc
NLP Software Engineer at Realyze Intelligence | Medical Research and Development
-
Nathaniel Brauser
Student at University of Pittsburgh studying computer science and data science.
Updates
-
🌽 🚜 🌾 it is Harvest season in the Heartland 💛 🤔 .... but what does that have to do with data? Or patients? Or AI? During last week's webinar, Dr. Matthew Lunning of the University of Nebraska Medical Center used a timely analogy that we loved, "If we were harvesting corn the same way as we were 50 years ago, the harvest, the yields would not be the same. But we have adapted the way we plant and harvest the corn." "So I think we need to be thinking the same way when we do data plowing. We're getting deeper and deeper and we're getting more bites of data ... but we have to be good stewards of the back end harvest of that data for it actually to be valuable and implementable in clinical trials" 👨🌾 In a world where patient data is growing exponentially, what solutions are you implementing to be a good data steward come harvest time? The Realyze platform is your ideal data harvest tool. It is fit for purpose for clinical trials and intentionally designed to ensure that patient data is sustainably structured and accessible for quality improvement research, feasibility queries and so much more. #ClinicalTrials #DataHarvest #GoodDataStewardship #NoMoreZombieTrials #ClinicalTrialsforAll #AIinPrecisionOncology #ClinicalTrialInnovation #DecentralizedTrials #CancerX #DigitalHealthInnovation #DHAI2024
-
Yesterday's webinar hosted by Center for Connected Medicine, Institute for Precision Medicine & UPMC was a total joy. The discussion spanned a wide array of topics but one of the key takeaways echos ones of our core beliefs : "AI can't replace the clinician... We need to use AI to augment workflows and improve efficiencies." The Realyze platform is designed to support & empower clinicians to identify the right patients at the right time for open & enrolling clinical trials at their institution. We take it a step further to enable the curation of patient data for feasibility queries, quality improvement research and personalized care enablement. Huge kudos to Dr. Adrian Lee for a kicking off the event and to Nicole Ansani for moderating the continued discussions. We especially appreciate Stefan Harrer, PhD of CSIRO's Data61 & Dr. Matthew Lunning of University of Nebraska Medical Center for joining our CEO Aaron Brauser on the panel. Missed the live event? No biggie! Watch the replay HERE ➡️ https://lnkd.in/g-iMUzZ7 #ClinicalTrialsForAll #NoMoreZombieTrials #AIinPrecisionOncology #AIOncology #CloseTheCareGap #ClinicalTrialInnovation #DecentralizedTrials #SCRS2024 #SOCRA2024
-
Realyze Intelligence reposted this
💡Live now with experts from UPMC, CSIRO's Data61, Institute for Precision Medicine, University of Nebraska Medical Center, and Realyze Intelligence discussing how health systems can leverage #AI to enhance clinical trials. Join now ➡️ https://lnkd.in/eKqt9ZYU
-
Realyze Intelligence reposted this
Live Now ➡️ Experts from the Institute for Precision Medicine (Adrian Lee) UPMC (Nicole Ansani), Realyze Intelligence (Aaron Brauser), CSIRO's Data61 (Stefan Harrer, PhD), and University of Nebraska Medical Center (Matthew Lunning) are discussing, "Optimizing Clinical Trials at Health Systems: The Opportunity for AI." 💡It isn't too late to be part of the conversation, link to join: https://lnkd.in/eKqt9ZYU
-
🚨❗TOMORROW : Thursday - Oct 3rd at 3:00pm ET - The Center for Connected Medicine at UPMC is hosting a webinar entitled : "Optimizing Clinical Trials at Health Systems: The Opportunity for AI" This insightful discussion will be moderated by Nicole Ansani, Senior Vice President of New Development Initiatives at UPMC Enterprises The expert panel will include Realyze Intelligence's very own CEO Aaron Brauser along with Matthew Lunning from the University of Nebraska Medical Center and Stefan Harrer, PhD, from CSIRO's Data61. The panelists will explore the transformative potential of #AI in #clinicaltrials - no surprise, we're pretty pumped to share our perspective! 🔗 Last chance to register HERE : https://lnkd.in/eRscpqUP #ClinicalTrialsForAll #CancerX #CancerXAccelerator #NoMoreZombieTrials #AIOncology #AIinPrecisionOncology #ClinicalTrialInnovation
-
Realyze Intelligence reposted this
Nucleate Pittsburgh is excited to unveil the official BioHack 2024 Problem Statements, our Keynote Speaker, and Schedule! Tackle real-world challenges with our Industry Partners: 🔸Cloud Lab Challenge – Emerald Cloud Lab 🔸BioTech – Tracer, DNAnexus, Rezq Bio, Aether, EDA CLINICAL 🔸HealthTech – Advanced Optronics, Asher Informatics PBC, PerforatedAI, KnitFit, Realyze Intelligence, Rewyndr Check out the problem statements on our website: https://lnkd.in/e3CXF6S5 You will get a chance to work with the experts from our Industry Partners at this weekend long event! Introducing our BioHack 2024 Keynote Speaker: D.J. Kleinbaum, PhD, Co-founder of Emerald Cloud Lab! To learn more about Dr. Kleinbaum’s keynote speech, as well as a detailed schedule for the weekend, check out the link below! 👇 https://lnkd.in/eBtBjCpz 👨🔬Be sure to check back on October 8th to find out who our BioHack 2024 mentors and judges will be! 🕰 Spots are filling fast - register before it’s too late! Don’t miss your chance to participate in Pittsburgh’s premier life sciences competition! 🗓️Event Dates: Friday October 25th - Sunday, October 27th 2024 🔗Register Here: https://lu.ma/dbxu6jh9 🌐More Info: www.nucleatepgh.xyz 🤝Partner with NucleatePGH: https://lnkd.in/euHCV8p8 Thank you to our Partners!
-
Realyze Intelligence reposted this
🔜 JOIN US THIS WEEK FOR OUR NEXT LIVE WEBINAR: 'Optimizing Clinical Trials at Health Systems ▶️ The Opportunity for #AI' 👉 Save your spot now: https://lnkd.in/eKqt9ZYU Experts from UPMC, Realyze Intelligence, CSIRO's Data61, and University of Nebraska Medical Center join virtual discussion on #AI’s potential to enhance #clinicaltrials efficiency and equity. Panelists will answer audience questions during the discussion. Curious about the latest advancements in clinical trials? Check out the articles below ⤵️ - https://lnkd.in/em_dCGBk (Patient Enrollment to Industry-Sponsored Versus Federally Sponsored Cancer Clinical Trials) - https://lnkd.in/esXjb99n (New Guide From NIH Collaboratory Promotes Health Equity in Pragmatic Clinical Trials) - https://lnkd.in/dc8E5VdX (How clinical trials can use AI responsibly and effectively) - https://lnkd.in/gGUdWayF (Adaptive trial designs will increase clinical trial speed, safety, and effectiveness)
-
Realyze Intelligence reposted this
Our partners are already using the Realyze platform to : ✅ Accelerate precise patient matching to clinical trials ✅ Slay zombie trials & inform clinical trial feasibility queries ✅ Turbocharge Real World Data driven research questions ✅ Implement right sized care to improve patient outcomes ✅ Simplify & expedite data registry abstraction Our CEO Aaron Brauser says it best: 🔬 💡 "We kind of look at it as like a microscope... until someone invented the microscope, there weren't a lot of cell level discoveries that happened. Once we get this data and the technology there, we're going to be able to find new ways to use the data and have abilities to solve problems we couldn't have even imagined." What will YOU do with the Realyze platform? Schedule time so we can solve BIG problems together : https://lnkd.in/gn5DsJkT #AIinPrecisionOncology #AIOncology #ClinicalTrials #ClinicalTrialInnovation #CloseTheCareGap #AIforGood #NoMoreZombieTrials #RealyzeIntelligence #CancerX
-
Realyze Intelligence reposted this
Don't miss an exciting discussion on the opportunities for #AI application in #clinicaltrials on Thursday, Oct. 3, at 3 pm ET! 🌟⚙️ Hosted by the Center for Connected Medicine and Institute for Precision Medicine, attendees will hear the latest indudstry insights from distinguished panelists from UPMC Enterprises, Realyze Intelligence, CSIRO, and University of Nebraska Medical Center. 🔗 Register today using the link below! https://lnkd.in/eKqt9ZYU